Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

802131

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what changes there have been in the (a) assessment and (b) management of motor neurone disease in the last 12 months.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117818
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>On 24 February 2016, the National Institute for Health and Care Excellence (NICE) published a new best practice guideline on the assessment and management of motor neurone disease (MND) and in July 2016 published a corresponding Quality Standard (QS), which sets out five key markers of high quality MND care. NICE routinely reviews its guidance to ensure that it reflects the latest available evidence, and it reviewed its QS earlier this year. Both the guideline and QS, along with information about the next planned review dates for both, can be found at the following links:</p><p><a href="http://www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149" target="_blank">www.nice.org.uk/guidance/ng42/resources/motor-neurone-disease-assessment-and-management-1837449470149</a></p><p> </p><p><a href="http://www.nice.org.uk/guidance/qs126" target="_blank">www.nice.org.uk/guidance/qs126</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:45:13 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

802144

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what estimate his Department has made of number of adults annually giving up smoking as a result of vaping; and whether there has been an increase in the number of adults giving up smoking since vaping became more common practice.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117831
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The Office for National Statistics has published data on e-cigarette use in England annually since 2014. Data is published at the following link:</p><p><a href="https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/ecigaretteuseinengland" target="_blank">https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandlifeexpectancies/datasets/ecigaretteuseinengland</a></p><p>The statistics show that in 2014 there was a total of 1.6 million e-cigarette users with 0.6 million of those ex-cigarette smokers. In 2016 e-cigarette use had increased to 2.4 million users, with 1.3 million of those ex-cigarette smokers. Smoking prevalence in England is currently at 15.5%, the lowest it has ever been.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:38:30 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

802274

registered interest
date	06/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Fracking: Health Hazards
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what discussions his Department has had with Public Health England on updating its report of 2014 on the effect of shale gas on public health.
tabling member constituency	Fylde
tabling member printed	Mark Menzies
uin	117961
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Public Health England (PHE) reviews the evidence base on the health impacts of chemical and radiological emissions associated with shale gas extraction as it emerges, considering the available evidence as a whole. Currently, PHE has not identified any significant new evidence that would make the Department change its view that the potential risks to public health from exposure to emissions associated with shale gas extraction will be low if operations are properly run and regulated. This means that good on-site management and appropriate regulation of all aspects from exploratory drilling, gas capture, use and storage of fracking fluid, and post-operations decommissioning are essential to minimise the risk to the environment and public health. If significant new evidence emerged this would be discussed with the Department of Health and other Government departments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:35:39 answering member 4067 label Biography information for Steve Brine
tabling member	3998 label Biography information for Mark Menzies

800927

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Drug: Misuse
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Advisory Council on the Misuse of Drugs report Commissioning impact on drug treatment which published in September 2017, what assessment he has made of the effect of reductions in funding for local authorities on the availability of drug misuse treatment in England.
tabling member constituency	Manchester, Withington
tabling member printed	Jeff Smith
uin	117486
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Officials are currently reviewing the report by the Advisory Council on the Misuse of Drugs entitled Commissioning impact of on drug treatment published on 6 September. The Government will respond shortly.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:39:29 answering member 4067 label Biography information for Steve Brine
tabling member	4456 label Biography information for Jeff Smith

800952

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Prostate Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of trends in the rates of prostate cancer among men over 50 who are (a) white and (b) BAME during the last ten years.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	117511
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>Data on the rates of prostate cancer among men over 50 are not held in the format requested.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:37:22 answering member 4067 label Biography information for Steve Brine
tabling member	1409 label Biography information for Mr Gregory Campbell

800962

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Infant Foods: Marketing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health what assessment he has made of the potential merits of fully implementing the International Code of Marketing of Breastmilk Substitutes after the UK leaves the EU.
tabling member constituency	Glasgow Central
tabling member printed	Alison Thewliss
uin	117521
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The Infant Formula and Follow-on Formula Regulations 2007 implements European Commission Directive 2006/141/EC on infant formulae and follow-on formulae, which gives effect to the principles and aims of the 1981 World Health Organization Code on the Marketing of Breastmilk Substitutes dealing with marketing, information and responsibilities of health authorities. There are no plans to review this legislation after the United Kingdom leaves the European Union.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:40:18 answering member 4067 label Biography information for Steve Brine
tabling member	4430 label Biography information for Alison Thewliss

800996

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Shingles: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps his Department is taking to increase the rates of uptake of the shingles vaccine
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
uin	117555
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>In conjunction with NHS England and the Department, the eligibility criteria for this vaccine have been changed to make it easier for health care professionals (HCPS) to identify eligible patients. This change means that patients become eligible for the vaccine from their 70th and 78th birthdays (if not previously vaccinated) and can be offered the vaccine opportunistically all year round.</p><p> </p><p>In support of this change, Public Health England has updated communication materials to both patients and HCPs to better illustrate eligible cohorts. This includes guidance for those in age groups with previous eligibility who have missed the opportunity to receive the vaccine, up to their 80th birthday.</p><p> </p><p>NHS England has a focus on reducing variation in all Section 7a immunisation programmes and work with local teams to seek assurance that low uptake and variation are addressed, and to identify good practice that can be shared.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:43:52 answering member 4067 label Biography information for Steve Brine
tabling member	4243 label Biography information for Dan Jarvis

801021

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Novartis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the potential effect of the relocation of the European Medicines Agency on the future of the Novartis pharmaceutical (a) site and (b) production at that site.
tabling member constituency	Great Grimsby
tabling member printed	Melanie Onn
uin	117580
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>The Government is committed to ensuring a positive outcome for the whole life science sector that enhances competitiveness and builds on the success that we are rightly proud of, as we exit the European Union. Officials across government have been carrying out a programme of sectoral and regulatory analysis to identify the key factors for the life sciences sector that will affect our negotiations with the EU. Ultimately it is for the European Medicines Agency to comment on how it intends to operate from its new location, and what individual companies like Novartis might have to do differently.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:40:39 answering member 4067 label Biography information for Steve Brine
tabling member	4464 label Biography information for Melanie Onn

801207

registered interest
date	05/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Clinical Commissioning Groups: Procurement
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, on how many occasions an NHS clinical commissioning group has been pursued by a care or health provider over deficiencies in the contract tendering procedure.
tabling member constituency	Edinburgh North and Leith
tabling member printed	Deidre Brock
uin	117766
answer	answer is ministerial correction date of answer 11/12/2017 answer text <p>NHS England has advised that they do not collect this information centrally.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 11/12/2017 17:36:28 answering member 4067 label Biography information for Steve Brine
tabling member	4417 label Biography information for Deidre Brock

800500

registered interest
date	04/12/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Scarlet Fever
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment his Department has made of the reasons for the recent rise in scarlet fever cases across England.
tabling member constituency	Leicester South
tabling member printed	Jonathan Ashworth
uin	117121
answer	answer is ministerial correction date of answer 07/12/2017 answer text <p>Public Health England has undertaken detailed analysis of scarlet fever notifications in England and Wales, collected as part of the statutory notifications of infectious diseases, to understand the possible cause of the rise in scarlet fever cases. Assessment of strains collected from scarlet fever patients across England as part of this investigation ruled out the emergence of a new strain as the cause of this rise. Longitudinal assessment of notifications since 1911 identified periodic surges in disease but all of relatively smaller magnitude to that seen during this current resurgence. The assessment is available at:</p><p><a href="http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr" target="_blank">http://www.thelancet.com/journals/laninf/article/PIIS1473-3099(17)30693-X/fulltext?elsca1=tlpr</a></p><p>The data collected has shown that cases reported during the rise are similar to previous cases in terms of seasonal pattern of occurrence, demographic characteristics, and frequency of hospitalisation.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2017 15:13:24 answering member 4067 label Biography information for Steve Brine
tabling member	4244 label Biography information for Jonathan Ashworth